Google Brains Bolted Days Shake Alphabet Stock and AI Bets
In seven days, five senior Google AI researchers resigned, fueling concerns that Alphabet is losing its AI edge. The ...
Which Total Market Fund Has The Lowest Expense Ratio
Discover how to determine which total market fund has the lowest expense ratio, plus practical steps to compare options effectively.
28,590 articles
Hess Midstream: Spending Winding Down to Big Free Cash Flow
Hess Midstream signals a major shift from expansion to cash returns, projecting $850-$900 million in adjusted free ca...
Scrolling UBI: Deloitte’s Fastest-Growing Mobile App
PulsePlay tops Deloitte’s North American fastest-growing software list, catalyzing investor interest as users earn mo...
Kevin Warsh's First Press Conference Shapes Fed Outlook
Inflation remains stubborn as the Fed prepares to hold rates steady. kevin warsh's first press conference will be scr...
Cardano Price Prediction: Hard Fork Sparks Fresh Momentum
Cardano's ADA is set for a major upgrade while traders watch a tight price range. Regulatory clarity and cross-chain ...
AI Is Turning Workers Into Superhumans, Leaders Lag
AI is accelerating frontline work even as executive teams struggle to adapt. Leaders must redesign decision-making to...
Climate Tech Exec: Europe Swelters, America Found AC Fix
Europe endures a blistering heatwave as the U.S. relies on widespread air conditioning. A climate tech executive outl...
Barclays Thinks Ionis Headed Toward a $106 Target This Year
Barclays has boosted its Ionis target to $106, signaling a roughly 46% upside from recent levels as olezarsen eyes pe...
FairGambling Launches Crypto Casino Review Platform
FairGambling unveils a new crypto casino review and analytics platform combining on-chain insights, provably fair ver...
This Number Helps Explain Why Americans Feel Down Right Now
A single metric helps explain the uneasy mood among Americans: the declining share of income going to workers as prof...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Post-Earnings Sell-Off Could Incredible Buying Opportunity
Earnings season often brings volatility, but a post-earnings sell-off could incredible offer a rare entry point for p...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status